One-stage Adjustable Strabismus Surgery Under AIVOC

Sponsor
Clinique Saint Jean, France (Other)
Overall Status
Completed
CT.gov ID
NCT04261699
Collaborator
(none)
159
1
18.1
8.8

Study Details

Study Description

Brief Summary

The purpose of this study is to note that one-stage adjustable surgery can be enough to provide satisfactory results for the correction of strabismus in adults thanks to the use of an anesthesia type AIVOC (Target-controlled infusion of Propofol-Remifentanyl)

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Adjustable surgery is a surgical treatment technique for strabismus and oculomotor paralysis well known and widely used around the world. The adjustable surgery is done in 2 steps. The first step, performed under general anesthesia, is practically the same as "classic" strabismus surgery however one or more muscles are fixed by temporary sutures. In a second time once the patient is awake and after a new clinical examination the sutures are adjusted and definitively fixed. The adjustment is sometimes made the same day but more often the day after the first intervention because it requires a state of consciousness close to normal.

    Anesthesia type Intravenous Intensity Concentration Anesthesia (AIVOC) allows the realization of a surgery under anesthesia general deep (choice of a cerebral or plasma anesthetic target suitable for surgery) but allows a programmed awakening, very fast in full consciousness, condition of an immediate reliable adjustment practically upon stopping the infusion of the anesthetic agent.

    The goal is to present an adjustable surgery technique simplified from a logistical point of view since performed in a single step thanks to the contribution of Intravenous Anesthesia with Concentration Objective (AIVOC) and to show that its results are equivalent to a second deferred time.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    159 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    One-stage Adjustable Strabismus Surgery Under AIVOC
    Actual Study Start Date :
    Jan 28, 2020
    Actual Primary Completion Date :
    Jun 30, 2021
    Actual Study Completion Date :
    Jul 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Need for a second adjustement time [The day after the intervention]

      Use of a second adjustment time the day after surgery

    Secondary Outcome Measures

    1. Digital visual scale to assess pain of patient [Before the intervention, before the intervention and one month after the intervention]

      Numeric scale numbered from 0 to 10. 0 : no pain, 10 : worst pain possible

    2. Patient comfort assessment questionnaire [5 minutes after the end of the intervention]

      This is a question to determine the comfort of the patient immediatly after the intervention. Very comfortable Comfortable Less comfortable Uncomfortable Very uncomfortable

    3. Patient satisfaction questionnaire [5 minutes after the end of the intervention]

      Numeric scale numbered from 0 to 10. 0 : unsatisfied, 10 : very satisfied

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient with medical insurance

    • Major patient requiring a strabismus surgery

    • Patient who received information about study and not having expressed their opposition to participate in the study

    Exclusion Criteria:
    • Minor patient

    • Patient participation in another interventional study

    • Patient having expressed their opposition to participate in the study

    • Patient for whom it is impossible to give informed information

    • Patient under the protection of justice, under curatorship ou under tutorship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Clinique Saint Jean Montpellier Hérault France 34000

    Sponsors and Collaborators

    • Clinique Saint Jean, France

    Investigators

    • Principal Investigator: Erick LAURENT, MD, Clinique Saint Jean, Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Clinique Saint Jean, France
    ClinicalTrials.gov Identifier:
    NCT04261699
    Other Study ID Numbers:
    • LOCAL2019-EL01
    First Posted:
    Feb 10, 2020
    Last Update Posted:
    Aug 25, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Clinique Saint Jean, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 25, 2021